Pembrolizumab related Guillain barre syndrome, a rare presentation in a patient with a history of lupus and bladder cancer
Immune checkpoint inhibitor-related neurotoxicity causing Guillain Barre Syndrome is relatively uncommon. We discussed an 80-year-old patient with known systemic lupus erythematosus who presented with lower extremity weakness, areflexia and then progressed to respiratory muscle and upper extremity w...
Main Authors: | Vikram Sangani, Mytri Pokal, Mamtha Balla, Ganesh Prasad Merugu, Sreedhar Adapa, Srikanth Naramala, Venu Madhav Konala |
---|---|
Format: | Article |
Language: | English |
Published: |
Greater Baltimore Medical Center
2021-05-01
|
Series: | Journal of Community Hospital Internal Medicine Perspectives |
Subjects: | |
Online Access: | http://dx.doi.org/10.1080/20009666.2021.1903133 |
Similar Items
-
A case of neuromyelitis optica spectrum disorder with coexisting systemic lupus erythematosus
by: Vikram Sangani, et al.
Published: (2021-07-01) -
Treatment Considerations for Patients with Unresectable Metastatic Melanoma Who Develop Pembrolizumab-Induced Guillain-Barré Toxicity: A Case Report
by: Sivraj Muralikrishnan, et al.
Published: (2020-01-01) -
Pembrolizumab-Induced Severe Neuropathy in a Patient with Metastatic Urothelial Carcinoma after Achieving Complete Response: Guillain-Barré Syndrome-Like Onset
by: Shuntaro Aoki, et al.
Published: (2020-12-01) -
Back to basics: review on vitamin D and respiratory viral infections including COVID-19
by: Mamtha Balla, et al.
Published: (2020-11-01) -
Síndrome de Guillain-Barré
by: Giselle Maria Beneti, et al.
Published: (2006-05-01)